Workshop Seminars

All segments of the Pharmaceutical Supply Chain must remain attentive to their environmental footprint, encompassing the stages of development, manufacturing, marketing, utilization, and disposal or excretion of medications. This workshop will facilitate group activities and discussions, allowing participants to examine the current challenges and opportunities associated with the sustainable delivery of pharmaceuticals.

The workshop will cover cleanroom design, cleanroom standards, cleanroom testing and validation, and also touch on sustainability and some of the work that is being done in this area.

Biopharma pipelines are potent. Effective [highly] potent drug safety management is critical whether managing compliance and liability or in developing new processes and facilities. The workshop will cover key technical and commercial aspects of potent drug safety whether as drug substances or drug products and include the following:

Toxicological hazard assessment
Biopharmaceutical occupational health and safety risk assessments
Containment and Control - Engineering, Procedural and Personal

Come along and bring your most difficult questions!

Artificial Intelligence will have a profound impact on everyone attending this conference. However, many are confused by what it is, how it works and concerned by what it will do. The purpose of this 30 minute session is to help you understand more so that you may fear less.

1. Assessing Current Practices:
   This part examines the cost, resources, and time required to implement current best practices, using a detailed example of a batch manufacturing process—tracing steps from raw material procurement to the release of the final batch.
2. Exploring Advancement Opportunities:
   This collaborative segment delves into potential innovations in areas like supply chain, warehousing, manufacturing, packaging, quality control, quality assurance, regulatory compliance, and research and development.
3. Identifying Challenges and Risks:
   Guided by the presenters, this section tackles significant challenges encountered during the transition to becoming smarter, more agile, and intelligent, while also addressing the risks of staying behind in this evolution.
4. Journey of GMP Manufacturing Ltd:
   An illustrative example of developing a cutting-edge, intelligent, and agile factory, showcasing GMP Manufacturing Ltd’s progress as a leading CDMO (Contract Development and Manufacturing Organization).
5. Engaging Interactive Q&A:
   Closing with an engaging question-and-answer session, this segment invites active audience participation and contribution.